Skip to main content
Clinical Trials/EUCTR2021-000312-36-FR
EUCTR2021-000312-36-FR
Active, Not Recruiting
Phase 1

Impact of Post-Traumatic Stress Disorder Treatment by Reconsolidation Therapy on Fibromyalgia Syndrome - PTSD-FMS

Henri Laborit Hospital0 sites25 target enrollmentMarch 24, 2021

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Post-Traumatic Stress Disorder and fibromyalgia syndrome
Sponsor
Henri Laborit Hospital
Enrollment
25
Status
Active, Not Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 24, 2021
End Date
TBD
Last Updated
last year
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Henri Laborit Hospital

Eligibility Criteria

Inclusion Criteria

  • \- Adult over 18 years old
  • \- Diagnosis of fibromyalgia syndrome according to ACR 2016 criteria
  • \-PCL\-5 \> 44 suggesting the presence of a comorbid post\-traumatic stress disorder
  • \-Meet the DSM\-5 criteria for post\-traumatic stress disorder secondary to exposure to a traumatic event according to DSM\-5 criteria, both unique or repeated and regardless of the date or location of the traumatic event.
  • \-Pain relief treatment and/or psychotropic treatment stabilized for a period greater than or equal to two months.
  • \-Signature of a consent form
  • \-Patient able to understand and read french
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes

Exclusion Criteria

  • \-Psychotic disorders
  • \-Unstable bipolar disorder
  • \-Patients with a systolic blood pressure \< 100 mmHg or heart rate \< 55 as established during the initial visit
  • \-Significant anormal ECG
  • \-Medical contraindication to taking propranolol
  • \-Adverse reactions or previous intolerances to a beta blocker
  • \-Current intake of another beta blocker which can not be stopped during the protocol, regardeless the galenic.
  • \-Current intake of a drug with potential contraindication with the propranolol, according to the summary of product characteristics of the propranolol.
  • \-Patient under legal protection, under guardianship or under curatorship
  • \-Patient having suffered a head trauma for less than a year or with clinical symptoms and neurological sequelae

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not Yet Recruiting
Phase 4
A Clinical Study On Post Covid Stress Disorder And Its Homoeopathic ManagementHealth Condition 1: F431- Post-traumatic stress disorder (PTSD)
CTRI/2022/04/041620S VIKRAM
Not Yet Recruiting
N/A
Treatment of PTSD and Addictio
NL-OMON27175Arkin, Department of Research, Amsterdam, the Netherlands; University of Amsterdam, the Netherlands.205
Recruiting
N/A
Posttraumatic stress disorder with and without consequent addiction disorders: Putative differentiating role of the HPA-systemF43.1F43.8F10F11F12F13F14F15F16F17F18F19Post-traumatic stress disorderOther reactions to severe stressMental and behavioural disorders due to use of alcoholMental and behavioural disorders due to use of opioidsMental and behavioural disorders due to use of cannabinoidsMental and behavioural disorders due to use of sedatives or hypnoticsMental and behavioural disorders due to use of cocaineMental and behavioural disorders due to use of other stimulants, including caffeineMental and behavioural disorders due to use of hallucinogensMental and behavioural disorders due to use of tobaccoMental and behavioural disorders due to use of volatile solventsMental and behavioural disorders due to multiple drug use and use of other psychoactive substances
DRKS00010118Fachklinik St. Marienstift Dammer Berge400
Recruiting
Phase 3
Treatment of posttramaumatic stress disorders in patients in in-patient addiction rehabilitation with the EMDR-method - a randomized controlled trialF43.1Post-traumatic stress disorder
DRKS00009007Gesellschaft für Rehabilitationswissenschaften Nordrhein-Westfalen e.V. (GfR)158
Completed
N/A
Randomised Control Trial of the Effectiveness of Exercise Augmentation in Patients with Post Traumatic Stress DisorderPost Traumatic Stress DisorderMental Health - Other mental health disorders
ACTRN12610000579099Dr Simon Rosenbaum80